Overview

The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This study will examine whether the administration of galantamine is effective for improvement of attention and more effective for patients with serious disturbance of attention by administering galantamine to patients with Alzheimer's dementia and performing an attention test on baseline, week 4 and 12.
Phase:
Phase 4
Details
Lead Sponsor:
Janssen Korea, Ltd., Korea
Treatments:
Galantamine